SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (663)9/9/1997 8:22:00 AM
From: tonyt   of 2173
 
Henry, why didn't you say that you were mentioned in that story? You don't come across as the 'modest' type -- is it because 'thestreet' called you an "An obsessive Internet poster who dominates several sites with his exegeses on Ligand Pharmaceuticals", and an "unabashed tout -- and sometime nuisance -- of a stock he owns".

Also, the story point directly to you as the source of the LGND/J&J rumor: "Lately, Niman, who also posts as HenryNFox on America Online, has been wondering aloud about whom the San Diego biotech firm will choose as a partner for its new diabetes drug."

You also failed to mention that the story also cites a busted deal: "Negotiations between the company and Warner-Lambert (WLA:NYSE) are said to have been most recently switched off"

And as for a deal with Lily, the article also "cautions that completing a deal always takes longer than you think."

--Tony
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News